Selections from Richard Lehman’s Literature Review: February 17th
This week's topics include hospital variation in noninvasive cardiac imaging, percutaneous renal denervation in patients with treatment-resistant hypertension, and more.The post Selections from Richard...
View ArticleSelections from Richard Lehman’s Literature Review: February 24th
This week's topics include radiofrequency ablation vs. antiarrhythmic drugs as first-line treatment of paroxysmal AF, Symplicity HTN-1 and Symplicity HTN-3, and more.The post Selections from Richard...
View ArticleSelections from Richard Lehman’s Literature Review: March 10th
This week's topics include cognitive function and brain structure in type 2 diabetics after intensive lowering of BP and lipid levels, the association of β-blocker therapy with risks of adverse CV...
View ArticleNo Benefit Found in First Real Test of Renal Denervation
SYMPLICITY HTN-3, the eagerly awaited first rigorous test of renal denervation, shows that the real effect of the novel blood-pressure-lowering technology is dramatically lower than earlier...
View ArticleNegative Findings on Renal Denervation for Hypertension: Sweet SYMPLICITY?
Deepak L. Bhatt, co-principal investigator of the SYMPLICITY HTN-3 trial, discusses the trial's findings and their implications for clinical practice.The post Negative Findings on Renal Denervation for...
View ArticleSelections from Richard Lehman’s Literature Review: April 7th
This week's topics include SYMPLICITY HTN-3, CoreValve, MADIT-CRT, and more.The post Selections from Richard Lehman’s Literature Review: April 7th appeared first on CardioExchange.
View ArticleThe Uncertain Future of Renal Denervation
Following the spectacular crash and burn of the SYMPLICITY HTN-3 trial at the American College of Cardiology (ACC) meeting two weeks ago, the future of renal denervation (RDN) — the once highly...
View ArticleNew Device to Lower Resistant Hypertension Shows Early Promise
A novel implantable device appears to show early promise in the treatment of resistant hypertension. The “Coupler” device from ROX Medical is about the size of a paper clip and is delivered via a...
View ArticleSelections from Richard Lehman’s Literature Review: February 9th
This week's topics include the efficacy of a device to narrow the coronary sinus in refractory angina and an open-label trial comparing the Symplicity device with stepped drug treatment for resistant...
View ArticleCompanies Plan To Resume Renal Denervation Trials
Medtronic and Boston Scientific have announced plans to start phase 2 clinical trials this year for their updated renal denervation catheters. The once promising new technology is intended to treat...
View Article
